Related Experiment Video
Updated: Jul 17, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Overlapping anti-NMDAR encephalitis and multiple sclerosis: A case report and literature review
Pan Liu1, Hui Yan2, Haizhe Li1
1Department of Neurology, The Central Hospital of Shaoyang, Shaoyang, Hunan, China.
Abstract:
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune-mediated disease characterized by complicated neuropsychiatric symptoms and the detection of cerebrospinal fluid antibodies against the GluN1 subunit of the NMDAR. With the proposed clinical method, more anti-NMDAR encephalitis patients have been discovered since its first report. However, anti-NMDAR encephalitis overlapping with multiple sclerosis (MS) is rare. Herein we report a male patient with anti-NMDAR encephalitis who developed MS in mainland China. Furthermore, we summarized the characteristics of patients who were diagnosed with overlapping MS and anti-NMDAR encephalitis in previous studies. Additionally, we pioneered the use of mycophenolate mofetil in immunosuppressive therapy, providing a novel therapeutic alternative for overlapping anti-NMDAR encephalitis and MS.
Insights
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis overlapping with multiple sclerosis (MS) is rare. This study reports a case and introduces mycophenolate mofetil as a novel therapy for this rare condition.
Area of Science:
- Neuroimmunology
- Neurology
Background:
- Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis presents with severe neuropsychiatric symptoms and is diagnosed by detecting antibodies against the GluN1 subunit.
- While diagnostic methods have improved, the co-occurrence of anti-NMDAR encephalitis and multiple sclerosis (MS) remains exceptionally rare.
Approach:
- This report details a case of a male patient diagnosed with overlapping anti-NMDAR encephalitis and MS in mainland China.
- A comprehensive review of previously reported cases of this rare overlap syndrome was conducted.
- Mycophenolate mofetil was utilized as an immunosuppressive therapy, representing a novel therapeutic approach.
Key Points:
- The study highlights the rarity of anti-NMDAR encephalitis co-occurring with MS.
- It provides a clinical case from mainland China, expanding geographical data on this rare condition.
- Mycophenolate mofetil is presented as a potential new treatment option.
Conclusions:
- The successful use of mycophenolate mofetil offers a new therapeutic avenue for patients with overlapping anti-NMDAR encephalitis and MS.
- Further research into this rare autoimmune neurological overlap syndrome is warranted to understand its pathogenesis and optimize treatment strategies.
More Related Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
Related Concept Videos
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction